A chinese medicine, kuan-sin-yin decoction, improves liver function in hepatitis b virus carriers: A randomized, controlled study

Chia Jung Lee, Chen Hung Cheng, Yu Hsien Li, Chia Yu Liu, Chung Hua Hsu

研究成果: 雜誌貢獻文章

4 引文 (Scopus)

摘要

Objective: To examine the effects of a Chinese medical herb complex formula, Kuan-Sin-Yin (KSY) decoction, on hepatitis B virus (HBV) carriers. Methods: Of 86 HBV carriers, 57 who met the inclusion criteria completed this study from February 2011 to December 2011 in Taipei City Hospital, Taiwan. The participants were randomly assigned to one of two groups: the KSY group (n=29) and a control group (n=28) that received KSY diluted 16 times. The participants took one packet of decoction per day after dinner for 6 weeks. The major outcome measurements were the percentage reduction in alanine aminotransferase (ALT), aspartate aminotransferase (AST), and the log of the HBV DNA level. The other measurements included seroconversion of hepatitis B e antigen and responses to the World Health Organization Quality of Life-Brief Version (WHOQOL-BREF) and Short-Form-12. The measurements were collected before the first treatment and 6 weeks later. Results: In the KSY group, AST and ALT levels decreased significantly and the score on the physical component of WHOQOL-BREF increased significantly. However, in the control group, there was no significant change after 6 weeks of treatment. Only the KSY group had a significant percentage reduction in ALT (change, -25.2% versus -0.74% in the control group) after 6 weeks of treatment. No major adverse effects occurred after 6 weeks of treatment. Conclusions: KSY significantly improved ALT levels. The study suggests that a longer-term study testing the efficacy of KSY in a larger sample is warranted.

原文英語
頁(從 - 到)964-969
頁數6
期刊Journal of Alternative and Complementary Medicine
19
發行號12
DOIs
出版狀態已發佈 - 十二月 1 2013
對外發佈Yes

指紋

Hepatitis Viruses
Alanine Transaminase
Hepatitis B virus
Medicine
Liver
Aspartate Aminotransferases
Control Groups
Quality of Life
Hepatitis B e Antigens
Urban Hospitals
Taiwan
Meals
DNA

ASJC Scopus subject areas

  • Complementary and alternative medicine

引用此文

A chinese medicine, kuan-sin-yin decoction, improves liver function in hepatitis b virus carriers : A randomized, controlled study. / Lee, Chia Jung; Cheng, Chen Hung; Li, Yu Hsien; Liu, Chia Yu; Hsu, Chung Hua.

於: Journal of Alternative and Complementary Medicine, 卷 19, 編號 12, 01.12.2013, p. 964-969.

研究成果: 雜誌貢獻文章

@article{1d1c980c816e493dbf0afab29e364d61,
title = "A chinese medicine, kuan-sin-yin decoction, improves liver function in hepatitis b virus carriers: A randomized, controlled study",
abstract = "Objective: To examine the effects of a Chinese medical herb complex formula, Kuan-Sin-Yin (KSY) decoction, on hepatitis B virus (HBV) carriers. Methods: Of 86 HBV carriers, 57 who met the inclusion criteria completed this study from February 2011 to December 2011 in Taipei City Hospital, Taiwan. The participants were randomly assigned to one of two groups: the KSY group (n=29) and a control group (n=28) that received KSY diluted 16 times. The participants took one packet of decoction per day after dinner for 6 weeks. The major outcome measurements were the percentage reduction in alanine aminotransferase (ALT), aspartate aminotransferase (AST), and the log of the HBV DNA level. The other measurements included seroconversion of hepatitis B e antigen and responses to the World Health Organization Quality of Life-Brief Version (WHOQOL-BREF) and Short-Form-12. The measurements were collected before the first treatment and 6 weeks later. Results: In the KSY group, AST and ALT levels decreased significantly and the score on the physical component of WHOQOL-BREF increased significantly. However, in the control group, there was no significant change after 6 weeks of treatment. Only the KSY group had a significant percentage reduction in ALT (change, -25.2{\%} versus -0.74{\%} in the control group) after 6 weeks of treatment. No major adverse effects occurred after 6 weeks of treatment. Conclusions: KSY significantly improved ALT levels. The study suggests that a longer-term study testing the efficacy of KSY in a larger sample is warranted.",
author = "Lee, {Chia Jung} and Cheng, {Chen Hung} and Li, {Yu Hsien} and Liu, {Chia Yu} and Hsu, {Chung Hua}",
year = "2013",
month = "12",
day = "1",
doi = "10.1089/acm.2013.0136",
language = "English",
volume = "19",
pages = "964--969",
journal = "Journal of Alternative and Complementary Medicine",
issn = "1075-5535",
publisher = "Mary Ann Liebert Inc.",
number = "12",

}

TY - JOUR

T1 - A chinese medicine, kuan-sin-yin decoction, improves liver function in hepatitis b virus carriers

T2 - A randomized, controlled study

AU - Lee, Chia Jung

AU - Cheng, Chen Hung

AU - Li, Yu Hsien

AU - Liu, Chia Yu

AU - Hsu, Chung Hua

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Objective: To examine the effects of a Chinese medical herb complex formula, Kuan-Sin-Yin (KSY) decoction, on hepatitis B virus (HBV) carriers. Methods: Of 86 HBV carriers, 57 who met the inclusion criteria completed this study from February 2011 to December 2011 in Taipei City Hospital, Taiwan. The participants were randomly assigned to one of two groups: the KSY group (n=29) and a control group (n=28) that received KSY diluted 16 times. The participants took one packet of decoction per day after dinner for 6 weeks. The major outcome measurements were the percentage reduction in alanine aminotransferase (ALT), aspartate aminotransferase (AST), and the log of the HBV DNA level. The other measurements included seroconversion of hepatitis B e antigen and responses to the World Health Organization Quality of Life-Brief Version (WHOQOL-BREF) and Short-Form-12. The measurements were collected before the first treatment and 6 weeks later. Results: In the KSY group, AST and ALT levels decreased significantly and the score on the physical component of WHOQOL-BREF increased significantly. However, in the control group, there was no significant change after 6 weeks of treatment. Only the KSY group had a significant percentage reduction in ALT (change, -25.2% versus -0.74% in the control group) after 6 weeks of treatment. No major adverse effects occurred after 6 weeks of treatment. Conclusions: KSY significantly improved ALT levels. The study suggests that a longer-term study testing the efficacy of KSY in a larger sample is warranted.

AB - Objective: To examine the effects of a Chinese medical herb complex formula, Kuan-Sin-Yin (KSY) decoction, on hepatitis B virus (HBV) carriers. Methods: Of 86 HBV carriers, 57 who met the inclusion criteria completed this study from February 2011 to December 2011 in Taipei City Hospital, Taiwan. The participants were randomly assigned to one of two groups: the KSY group (n=29) and a control group (n=28) that received KSY diluted 16 times. The participants took one packet of decoction per day after dinner for 6 weeks. The major outcome measurements were the percentage reduction in alanine aminotransferase (ALT), aspartate aminotransferase (AST), and the log of the HBV DNA level. The other measurements included seroconversion of hepatitis B e antigen and responses to the World Health Organization Quality of Life-Brief Version (WHOQOL-BREF) and Short-Form-12. The measurements were collected before the first treatment and 6 weeks later. Results: In the KSY group, AST and ALT levels decreased significantly and the score on the physical component of WHOQOL-BREF increased significantly. However, in the control group, there was no significant change after 6 weeks of treatment. Only the KSY group had a significant percentage reduction in ALT (change, -25.2% versus -0.74% in the control group) after 6 weeks of treatment. No major adverse effects occurred after 6 weeks of treatment. Conclusions: KSY significantly improved ALT levels. The study suggests that a longer-term study testing the efficacy of KSY in a larger sample is warranted.

UR - http://www.scopus.com/inward/record.url?scp=84890319255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890319255&partnerID=8YFLogxK

U2 - 10.1089/acm.2013.0136

DO - 10.1089/acm.2013.0136

M3 - Article

C2 - 23863086

AN - SCOPUS:84890319255

VL - 19

SP - 964

EP - 969

JO - Journal of Alternative and Complementary Medicine

JF - Journal of Alternative and Complementary Medicine

SN - 1075-5535

IS - 12

ER -